Have you looked at the Vaccine Insert that comes from the manufacturer of this particular vaccine?? Has your doctor willing handed it to you before he shot you in the arm with the vaccine?? Have you even thought to ask about it.. or did you just assume that your doctor was giving you what you needed and what was in the best interest of your HEALTH!!!??
Ok so let us start ... Here is the Pamphlet I am referring to...
▪ 6 through 35 months of age (0.25 mL dose, intramuscular injection): - Two 0.25 mL doses approximately one month apart. (2.2)
▪ 36 months through 9 years of age (0.5 mL dose, intramuscular injection): - Two 0.5 mL doses approximately one month apart. (2.2)
▪ 10 years of age and older - A single 0.5 mL dose, intramuscular injection. (2.2)
Adults - A single 0.5 mL dose, intramuscular injection. (2.2)
So here we have the doses that are to be given... a BABY age 6-35 months is to receive the same dose as an adult!!?? a CHILD age 36mth - 9 years is to be given double the dose of an adult!!??
Has your doctor ever told you not to get this vaccine if you have a egg allergy??
Severe hypersensitivity to egg proteins or any component of the vaccine or life-threatening reactions after previous administration of any influenza vaccine.
If your doctor uses a multi-dose vial - be aware it does include Thermisol (Mercury Preservative)
Vaccination with Influenza A (H1N1) 2009 Monovalent Vaccine may not protect all recipients.
These are some of the events that have happened to people after receiving the vaccine:
Thrombocytopenia, lymphadenopathy, Anaphylaxis, other allergic/hypersensitivity reactions, GBS, convulsions, myelitis (including encephalomyelitis and transverse myelitis), facial palsy (Bell’s palsy), optic neuritis/neuropathy, brachial neuritis, syncope (shortly after vaccination), dizziness, paresthesia, Vasculitis, vasodilation/flushing, Dyspnea, pharyngitis, rhinitis, Stevens-Johnson syndrome, Fever, pain, pruritis, asthenia/fatigue, pain in extremities, chest pain .... SOUNDS PLEASANT!!
Neither Fluzone vaccine nor Influenza A (H1N1) 2009 Monovalent Vaccine have been evaluated for carcinogenic or mutagenic potential, or for impairment of fertility
Influenza A (H1N1) 2009 Monovalent Vaccine, an inactivated influenza virus vaccine, for intramuscular use, is prepared from influenza viruses propagated inembryonated chicken eggs. The virus-containing allantoic fluid is harvested and inactivated with formaldehyde. Influenza virus is concentrated and purified in a linear sucrose density gradient solution using a continuous flow centrifuge. The virus is then chemically disrupted using a non-ionic surfactant,polyethylene glycol p-isooctylphenyl ether (Triton® X-100), producing a “split virus”. The split virus is further purified and then suspended in sodium phosphate-buffered isotonic sodium chloride solution. Influenza A (H1N1) 2009 Monovalent Vaccine is formulated to contain 15 mcg hemagglutinin (HA) of influenza A/California/07/2009 (H1N1) v-like virus per 0.5 mL dose. Gelatin 0.05% is added as a stabilizer. Each 0.5 mL dose may contain residual amounts of formaldehyde (not more than 100 mcg), polyethylene glycol p-isooctylphenyl ether (not more than 0.02%), and sucrose (not more than 2.0%).